Traditional needle-based injections can cause pain, variable drug dispersion, and inconsistent tissue depth delivery, leading to suboptimal outcomes in aesthetic and dermatological treatments. These limitations can hinder the effectiveness of therapies and reduce patient satisfaction.

RheoTek Medical is developing a needle-free injection technology platform designed for precise and painless drug delivery in aesthetics, dermatology, and oncology. The platform enables clinicians to administer injections at predetermined tissue depths (epidermis, dermis, fat, or muscle) with optimal drug dispersion. By eliminating the needle, the technology aims to reduce pain, improve treatment efficacy, and enhance the patient experience. The technology is designed to improve and achieve reproducible outcomes while also supporting novel therapeutics.

Needle-free injection technology for reduced pain and improved patient comfort

Precise control over injection depth for targeted drug delivery

Optimized drug dispersion within the tissue

Platform adaptable for various applications including face and hair aesthetics, medical dermatology, and skin cancer treatment

The primary target audience includes medical professionals in face and hair aesthetics, medical dermatology, and skin cancer treatment.